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Abstract
Rationale: Crystalline light chain inclusion-associated kidney disease affects mainly tubular epithelial cells and is often clinically
manifested as Fanconi syndrome. However, only very few case reports about the crystalline deposits within the podocytes are
available, and the nature of the pathogenic monoclonal light chain implicated in these cases is still unknown. We report a case of
crystalline inclusion-associated kidney diseasemanifested as crystalline podocytopathy in which we identiﬁed the complete structure
of the pathogenic monoclonal light chain as belonging to the germ-line gene of Vk1-39.
Patient concerns:We describe a 65-year-old woman with crystalline light chain inclusion-associated kidney disease showing
mild proteinuria and renal insufﬁciency with monoclonal gammopathy of undetermined signiﬁcance without Fanconi syndrome. She
had crystalline inclusions mainly within podocytes, tubular epithelial cells and histiocytes in the kidney. Light microscopy showed
vacuolation of podocytes and tubular epithelial cells, while eosin negative pale needle-like crystals were present within these cells.
Electron microscopy showed accumulation of club-like crystals with high electron density in podocytes, proximal tubular epithelial
cells and interstitial histiocytes. Clonal analysis revealed that a pathogenic monoclonal light chain was derived from germline gene,
Vk1-39.
Diagnoses: The diagnosis of crystalline light chain inclusion-associated kidney disease was made.
Interventions andoutcomes:Bortezomib and dexamethasone were started and her renal function improved to eGFR 36mL/
min/1.73m2 after 9 courses of therapy.
Lessons:Patients with light chain crystalline podocytopathy may have a similar pathogenic monoclonal light chain derived from the
same germline gene, Vk1–39, to that of patients with light chain proximal tubulopathy.
Abbreviations: CDR = complementarity-determining region, eGFR = estimated glomerular ﬁltration rate, LCPT = light chain
proximal tubulopathy, MGUS=monoclonal gammopathy of undetermined signiﬁcance, PTE= proximal tubular epithelial cells, sCr =
serum creatinine.
Keywords: crystal-storing histiocytosis, light chain, light chain proximal tubulopathy, podocyteEditor: N/A.
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Plasma cell dyscrasia often induces renal dysfunction associated
with monoclonal immunoglobulin. In most cases, monoclonal
immunoglobulin accumulates extracellularly as casts, ﬁbers, or
granules resulting in cast nephropathy, amyloidosis, or mono-
clonal immunoglobulin deposition disease.[1] On the other hand,
although very rare, the entity of crystalline light chain inclusion-
associated kidney disease in which monoclonal light chain
crystalline accumulates within cells also exists.[2] In this
condition, crystalline inclusions form mainly within the tubular
epithelial cells. This condition is referred to as light chain
proximal tubulopathy (LCPT), and often induces Fanconi
syndrome clinically.[3,4] Interestingly, light chain crystalline
deposits can be formed within the podocytes.[5–15] In such cases,
not Fanconi syndrome but proteinuria, nephrotic syndrome, or
renal insufﬁciency are the main clinical manifestations. However,
only very few case reports about the crystalline deposits within
the podocytes are available, and the nature of the pathogenic
monoclonal light chain implicated in these cases is still unknown.
Here, we report a case of crystalline inclusion-associated kidney
disease manifested as crystalline podocytopathy in which we
identiﬁed the complete structure of the pathogenic monoclonal
light chain as belonging to the germ-line gene of Vk1-39.
2. Case
A 65-year-old Japanese woman was admitted to our hospital for
close examination of decreased renal function. Her father had
cardiac disease and her mother had liver cirrhosis. When she
developed maxillary sinusitis 3 years before, renal insufﬁciency
was pointed out with a serum creatinine level (sCr) of 1.15mg/dL.
One year before admission, her sCr rose to 1.31mg/dL and urine
protein was 2.0g/gCr, but kidney biopsy revealed interstitial
ﬁbrosis and tubular atrophy without any glomerular abnormali-
ties, and the etiology could not be determined. Although she
had been treated with valsartan, her sCr gradually worsened to
1.94mg/dL.
On admission, her blood pressure was 110/60 mmHg, pulse
rate was 84/min, and body temperature was 36.2°C. The heart,
lungs, and abdominal ﬁndings were normal. No lower leg edema,
skin rashes, or neurological abnormalities were noted. Urinalysis
showed 2+ proteinuria, 2+ occult blood, and no glycosuria.
Urinary sediment showed neither granular nor red blood cell
casts. Proteinuria was 1.31g/gCr. Blood examination revealed
renal insufﬁciency [Cr 1.94mg/dL, estimated glomerular ﬁltra-
tion rate (eGFR) 21.0mL/min/1.73m2]. No evidence of Fanconi
syndrome was noted (uric acid 3.0mg/dL, sodium 139mEq/L,
potassium 3.9mEq/L, calcium 8.8mg/dL, phosphate 3.3mg/dL).
Her immunological data showed normal complement levels [C3
108mg/dL (normal: 44–102mg/dL), CH50 40U/mL (normal:
32–47U/mL)] but mild elevation of immunoglobulin G (IgG)
with decreased levels of IgA and IgM (IgG 2,259mg/dL, IgA 47
mg/dL, IgM 42mg/dL). Anti-nuclear antibodies were negative.
Immunoelectrophoresis revealed serum monoclonal IgG k and
urine k Bence-Jones protein. Because bone marrow biopsy
showed a plasma cell fraction of less than 10%, the diagnosis of
monoclonal gammopathy of undetermined signiﬁcance (MGUS)
was made.
On admission, a kidney biopsy was performed. The renal
specimens contained 17 glomeruli, 7 of which showed global
sclerosis. The tubulointerstitium showed diffuse interstitial
ﬁbrosis with some inﬂammatory cell inﬁltration (Fig. 1A). A
substantial number of proximal and distal tubular epithelial cells2had a foamy appearance (Fig. 1A–B) which consisted of eosin-
and trichrome-negative pale needle-like crystals (Fig. 1B). These
crystals were also present in the interstitium and glomerular
podocytes, showing a foamy appearance (Fig. 1B–C). The
glomeruli showed minor abnormalities (Fig. 1C). Immuno-
staining revealed CD68-positive macrophages containing the
needle-like crystals in the interstitium (Fig. 1D). Immunoﬂuores-
cence showed negative staining of IgG, IgA, IgM, C3, C1q, k, and
l. Electronmicroscopy showed accumulation of club-like crystals
with high electron density in proximal tubular epithelial cells
(PTE) and interstitial histiocytes (Fig. 1E–G). A similar
accumulation of club-like crystals with high electron density
was present in podocytes (Fig. 1F–H). The diagnosis of crystalline
light chain inclusion-associated kidney disease was made.
Bortezomib and dexamethasone were started and her renal
function improved to eGFR 36mL/min/1.73m2 after 9 courses of
therapy (Fig. 2).
3. Clonal analysis
The nucleotide sequence corresponding to the variable and
constant regions of pathogenic monoclonal kappa light chain was
determined using kappa speciﬁc primers and cDNAs synthesized
on a template of RNA extracted from bone marrow as previously
described.[16,17,18]
We identiﬁed a clone KL4–1 encoding a kappa light chain
predominantly expressed in bone marrow. The analysis of
nucleotide sequences revealed that its variable region is encoded
by the IGKV1 and IGKJ2 genes (Fig. 3A) and that the constant
region is unmutated and corresponds to the Km(3) allotype.
Although none of the known germ-line IGKV1 gene subgroups
were found to be identical to the KL4-1 Vk gene, the IGKV1-39
gene showed the highest homology (91%). The joining region
sequence differs from the IGKJ2 germ-line gene by 4 nucleotide
substitutions. The predicted amino acid sequence of the KL4-1
clone differs from that of the IGKV1-39 and IGKJ2 germ-line
genes by 15 and 3 amino acid substitutions, respectively,
including 4 in complementarity-determining region 1 (CDR1),
3 in CDR2 and 3 in CDR3 (Fig. 3B). Among those, we noted the
replacement of six unusual amino acid residues: negatively
charged glutamic acid for uncharged glutamine at position 27 in
CDR1, negatively charged aspartic acid for uncharged serine at
position 30 in CDR1, hydrophobic cysteine for tyrosine at
position 49 in framework region 2 (FR2), hydrophobic proline
for serine at position 56 in CDR2, hydrophobic alanine for
charged glutamic acid at position 81 in FR3 and charged aspartic
acid for serine at position 93 in CDR3. Signiﬁcantly, the use of the
same IGKV1-39 was reported for pathogenic monoclonal light
chains in all three cases (CHEB, TRE and TRO) of Fanconi
syndrome associated with the accumulation of crystals in PTE,[16]
while the Jk gene segment is different: IGKJ1 for CHEB, IGKJ3
for TRE and IGKJ4 for TRO.[16] Notably, amino acid sequences
of the Vk region of CHEB, TRE and TRO are considerably
different from that of our case (Fig. 3B). Moreover, none of the
above-mentioned unusual amino acid substitutions observed in
our case are present in these 3 cases.
4. Discussion
We experienced a case showing mild proteinuria and renal
insufﬁciency that was eventually identiﬁed as monoclonal
gammopathy of undetermined signiﬁcance (MGUS) with crys-
talline inclusions within the cells in the kidney. Crystalline
Figure 1. Light microscopy and electron microscopy ﬁndings of the patient. (A) Tubulointerstitium showed diffuse interstitial ﬁbrosis. Some proximal and distal
tubular epithelial cells were vacuolated (arrow) (Masson-Trichrome staining). (B) Eosin-negative pale needle-like crystals were present both in tubular epithelial cells
(black arrow) and interstitium (red arrow). Note that denuded cell contains the crystals in the tubular lumen (yellow arrow) (Periodic acid-Schiff methenamine silver
stain). (C) The glomeruli showed vacuolation of podocytes (arrows) without mesangial proliferation, endocapillary proliferation, or extracapillary proliferation (Periodic
acid-Schiff methenamine silver stain). (D) CD68 immunostaining revealed the presence of needle- or polygon-like crystals in CD68-positive macrophages. (E, G, H)
Electron microscopy showed accumulation of club-like crystals with high electron density in proximal tubular epithelial cells (yellow arrows, G) and interstitial
histiocytes (red arrow, H). (F, I) A similar accumulation of club-like crystals with high electron density was present in podocytes (arrows, I). (Original magniﬁcation,
A, 100, C, 200, B, D, 400, E, 600, F, 400, G, 6000, H, 7000, I, 5000).
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Figure 2. Clinical course. Her renal function improved after 9 courses of therapy. BD = Bortezomib and dexamethasone.
Ito et al. Medicine (2019) 98:5 Medicineinclusions were detected not only within the PTE but also
podocytes and histiocytes. Despite the presence of crystalline
deposits in the PTE, the patient did not show the manifestations
of Fanconi syndrome.
To the best of our knowledge, only 11 cases of crystalline
inclusion within the podocytes associated with plasma cell
dyscrasia have been reported.[4,5–15] Of these, nine had multiple
myeloma,[5,6,8,9,11–15] and two MGUS.[7,10] Interestingly, all
cases had IgG-k M-protein, with only one case exceptionally
manifesting clinical manifestations of Fanconi syndrome.[11]
Proteinuria is a representative clinical feature of crystalline
podocytopathy. About half of the patients had mild proteinuria,
while four had nephrotic range proteinuria.[6,10,12,13] Three of
these 4 had been diagnosed histopathologically with focal
segmental glomerulosclerosis.[6,10,12] Most patients had renal
insufﬁciency of various severities. However, renal glycosuria or
hypokalemia was rarely seen in this condition. The clinical and
histological features of our case are consistent with those of these
previous cases; however, the structure and pathogenicity of
monoclonal kappa on podocytes have not been determined in
crystal-storing histiocytosis.
It can be difﬁcult to identify crystalline inclusions asmonoclonal
k light chains by immunoﬂuorescence. In such cases, immunohis-
tochemical method using parafﬁn-embedded sections are useful
probably because antigenic epitopes are made accessible by anti-k
light chain antibodies through the antigen retrieval procedure.[4]
However, in some cases including our case, immunohistochemical
method also failed to identify crystalline inclusions as k light
chains. Jones et al speculated that negative immunostaining of
crystalline inclusions might be attributable to the inaccessibility of
crystalline deposits to anti-k light chain antibodies owing to their
highly crystallized structure.[19] Another possible explanation is
partial degradation of the pathogenic light chains. For either of
these reasons, we could not identify the crystalline deposits within
podocytes as k light chains in our case.
Previous studies on patients with crystalline light chain
inclusion-associated kidney diseases (or myeloma-associated
Fanconi syndrome displaying crystals in proximal tubular4epithelial cells) revealed that pathogenic monoclonal light chains
belong to the germ-line gene of IGKV1-39 (also known as Vk1-
39 or VkI O2/O12).[16,20,21] Although a number of amino acid
substitutions in the Vk region have been identiﬁed,[16,20,21] it has
been claimed that the substitution of a polar serine residue by a
non-polar hydrophobic amino acid residue, either alanine or
isoleucine, at position 30 of CDR1 plays a pathogenic role in the
formation of intracellular crystals within tubular cells.[21,22]
However, as shown in Fig. 2B, serine at position 30 was also
replaced by a hydrophobic leucine in the pathogenic light chain
isolated from a patient LEC with Fanconi syndrome but lacking
crystalline inclusion in tubular cells.[22] Notably, in our present
case, the amino acid residue at position 30 is substituted by a
negatively charged aspartic acid. Moreover, we identiﬁed 5 other
unusual, either hydrophobic or charged, amino acid substitutions
not observed in the previously reported cases of LCPT. Of those,
the presence of cysteine just next to the CDR2may be of potential
signiﬁcance because of the possible formation of a unique
structure of these light chains through the disulﬁde-bond
formation. If this is proved to be the case, further analysis with
its mutants would help deﬁne the pathogenic implications of these
unusual amino acid residues identiﬁed in our case. We have not
determined whether this monoclonal light chain sequence is truly
pathogenic. Now we are investigating whether the protein
encoded by this sequence causes crystalline inclusion in vivo and/
or in vitro.
Our present study strongly implicated the IGKV1-39 gene in
crystalline light chain inclusion-associated kidney diseases.
However, it needs to be stressed that the V region sequence of
our case differs considerably from those of previously reported
cases of LCPT that lacked both podocyte involvement and
clinically expressed Fanconi syndrome. This could be related to
differences in histopathological and clinical manifestations.
Clearly, further clonal analyses of patients with light chain
crystalline podocytopathy are needed to clarify why despite the
use of the same IGKV1-39 gene for pathogenic light chains, such
different histopathological and clinical pictures are induced in
these 2 diseases.
Figure 3. Sequence analysis of the variable region of the present patient with crystalline light chain inclusion-associated kidney disease. (A) Nucleotide and
predicted amino acid sequences of Vk region of clone KL4-1 isolated from the patient. The numbering of amino acid residues in the one-letter code and CDRs are
according to Mizuochi et al [23] The GenBank accession number for KL4-1 cDNA sequence is MH298056. (B) Comparison of the predicted amino acid sequence of
clone KL4-1 with those of light chains from previously reported cases of Fanconi syndrome with or without intracellular crystals[16,20,22] and with that of the IGKV1-
39 germ-line gene. Note that the accumulation of needle-like crystals within proximal tubular cells was reported in patients CHEB, TRE and TRO, but not in patient
LEC. Unique mutations in our patient are highlighted in grey. Identities are indicated with dots. X: undetermined amino acid residue.
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